**5. Conclusions**

CE-MRA seems to be a feasible method for the detection of PAVMs with a FAD ≥ 2 mm in HHT patients initially screened with TTCE. We are hopeful that future advancements in CE-MRA technology will reduce false positive rates and allow for more broad use of CE-MRA in PAVM diagnosis and management.

**Author Contributions:** Conceptualization: D.A.F.v.d.H., M.C.P., R.J.S., J.J.M. Methodology: D.A.F.v.d.H., M.C.P., J.J.M. Validation: J.C.K. Formal Analysis: J.C.K. Investigation: D.A.F.v.d.H., W.K. Data Curation: D.A.F.v.d.H., W.K. Writing–Original Draft Preparation: D.A.F.v.d.H. Writing–Review & Editing: M.C.P., H.W.v.E., R.J.S., J.-A.V. Visualization: D.A.F.v.d.H., H.W.v.E. Supervision: J.-A.V., J.J.M. Project Administration: W.K. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.
